Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aclarion (ACONW) Research & Development (2021 - 2025)

Historic Research & Development for Aclarion (ACONW) over the last 5 years, with Q3 2025 value amounting to $302037.0.

  • Aclarion's Research & Development rose 5426.03% to $302037.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 1922.38%. This contributed to the annual value of $888766.0 for FY2024, which is 176.68% up from last year.
  • According to the latest figures from Q3 2025, Aclarion's Research & Development is $302037.0, which was up 5426.03% from $270434.0 recorded in Q2 2025.
  • In the past 5 years, Aclarion's Research & Development registered a high of $353226.0 during Q2 2022, and its lowest value of $162714.0 during Q2 2021.
  • Moreover, its 5-year median value for Research & Development was $218997.0 (2022), whereas its average is $230979.3.
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 11708.4% in 2022, then crashed by 3186.42% in 2023.
  • Aclarion's Research & Development (Quarter) stood at $182101.0 in 2021, then grew by 20.26% to $218997.0 in 2022, then grew by 0.77% to $220679.0 in 2023, then rose by 14.11% to $251826.0 in 2024, then rose by 19.94% to $302037.0 in 2025.
  • Its last three reported values are $302037.0 in Q3 2025, $270434.0 for Q2 2025, and $198190.0 during Q1 2025.